Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?
about
Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomasEfficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trialDoes the addition of drugs targeting the vascular endothelial growth factor pathway to first-line chemotherapy increase complete response? A meta-analysis of randomized clinical trials.Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series.
P2860
Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Does complete response to syst ...... slate into long-term survival?
@en
Does complete response to syst ...... slate into long-term survival?
@nl
type
label
Does complete response to syst ...... slate into long-term survival?
@en
Does complete response to syst ...... slate into long-term survival?
@nl
prefLabel
Does complete response to syst ...... slate into long-term survival?
@en
Does complete response to syst ...... slate into long-term survival?
@nl
P2093
P1433
P1476
Does complete response to syst ...... slate into long-term survival?
@en
P2093
Agop Y Bedikian
Carla L Warneke
Jade Homsi
Kevin B Kim
Marcella M Johnson
Michelle Rohlfs
Nicholas E Papadopoulos
Patrick Hwu
Susan McIntyre
Wen-Jen Hwu
P356
10.1097/CMR.0B013E328341445F
P407
P577
2011-02-01T00:00:00Z